256 related articles for article (PubMed ID: 30031702)
1. Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study.
Lie ØH; Rootwelt-Norberg C; Dejgaard LA; Leren IS; Stokke MK; Edvardsen T; Haugaa KH
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1377-1386. PubMed ID: 30031702
[TBL] [Abstract][Full Text] [Related]
2. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
[TBL] [Abstract][Full Text] [Related]
4. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
[TBL] [Abstract][Full Text] [Related]
5. Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy: Association With Life-Threatening Ventricular Arrhythmias.
Kirkels FP; Lie ØH; Cramer MJ; Chivulescu M; Rootwelt-Norberg C; Asselbergs FW; Teske AJ; Haugaa KH
JACC Cardiovasc Imaging; 2021 May; 14(5):900-910. PubMed ID: 33582062
[TBL] [Abstract][Full Text] [Related]
6. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
te Riele AS; Bhonsale A; James CA; Rastegar N; Murray B; Burt JR; Tichnell C; Madhavan S; Judge DP; Bluemke DA; Zimmerman SL; Kamel IR; Calkins H; Tandri H
J Am Coll Cardiol; 2013 Nov; 62(19):1761-9. PubMed ID: 23810894
[TBL] [Abstract][Full Text] [Related]
7. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
8. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
[TBL] [Abstract][Full Text] [Related]
9. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
10. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
12. Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis.
Lie ØH; Chivulescu M; Rootwelt-Norberg C; Ribe M; Bogsrud MP; Lyseggen E; Beitnes JO; Almaas V; Haugaa KH
J Am Heart Assoc; 2021 Apr; 10(8):e018680. PubMed ID: 33821670
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
[TBL] [Abstract][Full Text] [Related]
16. Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Wang W; Orgeron G; Tichnell C; Murray B; Crosson J; Monfredi O; Cadrin-Tourigny J; Tandri H; Calkins H; James CA
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909402
[TBL] [Abstract][Full Text] [Related]
17. Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy.
Lie ØH; Dejgaard LA; Saberniak J; Rootwelt C; Stokke MK; Edvardsen T; Haugaa KH
JACC Clin Electrophysiol; 2018 Jun; 4(6):744-753. PubMed ID: 29929667
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
[TBL] [Abstract][Full Text] [Related]
20. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
